CRIS
Price
$0.36
Change
-$0.07 (-16.28%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
14.1M
37 days until earnings call
Intraday BUY SELL Signals
DMRA
Price
$22.87
Change
-$1.02 (-4.27%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.41B
43 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRIS vs DMRA

CRIS vs DMRA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRIS vs. DMRA commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Hold and DMRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (CRIS: $0.43 vs. DMRA: $23.84)
Brand notoriety: CRIS and DMRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 127% vs. DMRA: 144%
Market capitalization -- CRIS: $14.1M vs. DMRA: $1.47B
CRIS [@Biotechnology] is valued at $14.1M. DMRA’s [@Biotechnology] market capitalization is $1.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileDMRA’s FA Score has 1 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • DMRA’s FA Score: 1 green, 4 red.
According to our system of comparison, DMRA is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 3 TA indicator(s) are bullish while DMRA’s TA Score has 5 bullish TA indicator(s).

  • CRIS’s TA Score: 3 bullish, 5 bearish.
  • DMRA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DMRA is a better buy in the short-term than CRIS.

Price Growth

CRIS (@Biotechnology) experienced а +4.52% price change this week, while DMRA (@Biotechnology) price change was +18.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

CRIS is expected to report earnings on Jul 30, 2026.

DMRA is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DMRA($1.41B) has a higher market cap than CRIS($14.1M). DMRA YTD gains are higher at: 3.607 vs. CRIS (-55.972). CRIS has higher annual earnings (EBITDA): -6.64M vs. DMRA (-238.99M). DMRA has more cash in the bank: 533M vs. CRIS (15M). CRIS has higher revenues than DMRA: CRIS (7.06M) vs DMRA (0).
CRISDMRACRIS / DMRA
Capitalization14.1M1.41B1%
EBITDA-6.64M-238.99M3%
Gain YTD-55.9723.607-1,552%
P/E RatioN/AN/A-
Revenue7.06M0-
Total Cash15M533M3%
Total Debt1.34MN/A-
FUNDAMENTALS RATINGS
CRIS: Fundamental Ratings
CRIS
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
21

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRISDMRA
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CRIS
Daily Signal:
Gain/Loss:
DMRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSCI180.930.98
+0.55%
Invesco S&P SmallCap Industrials ETF
CAIE27.17-0.02
-0.07%
Calamos US Eq Autocallable Income ETF
TDAX25.87-0.12
-0.46%
TDAQ Lift ETF
XLSR64.95-0.59
-0.90%
State Street® US Sector Rotation ETF
MUSQ24.83-0.59
-2.32%
MUSQ Global Music Industry Idx ETF

CRIS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRIS has been loosely correlated with ORMP. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRIS jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRIS
1D Price
Change %
CRIS100%
+3.23%
ORMP - CRIS
34%
Loosely correlated
+3.09%
VTGN - CRIS
33%
Loosely correlated
-5.94%
AMRN - CRIS
30%
Poorly correlated
-1.15%
DMRA - CRIS
30%
Poorly correlated
+12.29%
ALGS - CRIS
30%
Poorly correlated
+7.39%
More

DMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMRA has been loosely correlated with COGT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DMRA jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMRA
1D Price
Change %
DMRA100%
+12.29%
COGT - DMRA
46%
Loosely correlated
+3.72%
NERV - DMRA
45%
Loosely correlated
+4.47%
INBX - DMRA
44%
Loosely correlated
+0.54%
RANI - DMRA
44%
Loosely correlated
-1.07%
GNTA - DMRA
38%
Loosely correlated
+14.88%
More